Prostate Cancer (PCa)
Home Back

 

Stephan L. Werner, M.D., F.A.C.S.

PCA SITE MAP

HOME

 

Site Map

 

 

Introduction 

 Demographics

 Anatomy & Physiology

 Symptoms

 Who Should be Evaluated

 Prostate Examination

 Digital Rectal

 PSA

 Total vs. Free Ratio

How to Evaluate for PCa

 Consultation

 Total vs. Free PSA

 Trans Rectal Ultrasound

 Needle Biopsy

 Biopsy Results

What if the Biopsy is Positive?

PIN

 How is Pin Diagnosed?

 Does Pin Raise PSA?

 What does PIN mean?

 Treatment of PIN

Gleason Grade

Stage

 Stage A

 Stage B

 Stage C

 Stage D

Therapy Options

Surgery

 Radical Prostatectomy

 Standard Operation    

 Nerve Sparing Oper.

 Positive Margins

 Recurrence after Surgery

Radiation Therapy

 External Beam Therapy

 IMRT

 Interstitial Radiotherapy

 Brachytherapy or Seeds

 Rapid Interstitial Therapy

 Combined Therapy

 Neoadjuvant Therapy or

         Hormones + Radiation

Combined Therapy

Cryotherapy

Hormone Therapy 

 Hormonal Therapy

 Castration

 LHRH Inhibitors

 Total Androgen Blockade

 Neo Adjuvant Therapy or

    Hormones + Radiation

Observation

Late Stage Prostate Cancer

 Cycling antiandrogens

 Chemotherapy

 Cryotherapy

 Bony Metastases

   External Beam Radiation

   Strontium 89

   Bisphosphonates

   Immunotherapy

   Monoclonal Antibodies

   Alternate Medicine

Alternate Medicine

 PC-Spes

 

PCA WEB MAP

 

 

 

 

 

 

 

Prostate Cancer, (PCa), is the most common cancer in men in the US today.   In 1997  there were 240,000 newly discovered cases and about 40,000 deaths.   These numbers have started to drop as the result of the development of a screening test, PSA, and much improved public awareness of the importance of seeking evaluation on a regular schedule.

    Prostate Cancer is much more common in the developed world, especially in western Europe and the Americas.  The causes are unknown but are probably related to lifestyle and dietary factors.  Heredity and race play roles in causation as there are families with a high incidence of prostate cancer, and it is much more frequently found in African Americans than Caucasians.  The disease is rare in Africa and Asia, but occurs more frequently in later immigrant generations.

    The disease is rare before age 40.  The incidence rises with age, and by age 80, 70+% of men will have prostate cancer, although the aggressiveness of the disease decreases with late age of onset.

 

Anatomy and Physiology

click to enlarge   The prostate gland, (very frequently  mispronounced prostRate), lies deep in the pelvis.  It surrounds the urethra, the urine tube running from the bladder, through the prostate and the penis. It is just in front of the rectum so that part of the gland         may be easily examined by a simple Digital Rectal click picture to enlarge       Examination, (DRE). In young men it is usually the size of a walnut, but may grow with age to the size of a lemon, or even larger.  It supports the ejaculatory ducts, or sperm tubes, but appears not to have any other function in humans.   

 

Symptoms

    Prostate cancer usually exists without symptoms!!!  Some patients may have symptoms of having to urinate frequently or slowly,  or have urinary burning or blockage or bleeding.  These symptoms usually come from other conditions such as infection or inflammation or overgrowth, but may be associated with prostate cancer.  When these symptoms occur the patient should seek urologic evaluation. When the cancer has spread, bone pain is a common symptom.   

Who Should be Examined for Prostate Cancer?

   All men over 50 and below 80 should have an annual prostate cancer examination.  All men over 40 with strong family histories, (fathers, brothers or any two close relatives), and all  African-American men over 40 should have an annual exam.  In those few families with multiple males having had prostate cancer screening might be considered at an earlier age.

    Prostate cancer is very common in men over 80, but is usually a slow growing, non life threatening disease.  Men over 80 should have an annual DRE for prostate and colorectal examination, and if the prostate is abnormal a PSA may be obtained. (See below under treatment).

The Prostate Examination

     The prostate examination consists of two parts, a digital rectal examination, (DRE), and a blood test, the PSA or, prostate specific antigen.  The combination of the two examinations significantly increases the detection of prostate cancer over either test alone.

 click to enlarge       The DRE is performed by the examiner gently inserting a finger into the rectum and palpating the gland for size, shape, consistency, and nodules or lumps.  The examiner may also check for colon  or rectal cancer or other conditions.  Prostate nodules should not be ignored.  Although about half of prostate nodules found will not be cancerous, the examiner cannot tell from the examination alone whether cancer is       present.  Some prostate cancers cannot be felt by  DRE because they lie in a click picture to enlarge      part of the gland that the finger cannot reach, or they are too small to feel or they just do not feel abnormal.   All nodules require further evaluation.

      PSA or Prostate Specific Antigen, is a blood test that helps detect prostate cancer.  PSA is a fuzzy test and cannot diagnose prostate cancer by itself!.  Many other conditions such as prostate  infection or inflammation, or urinary tract infection may raise the PSA.    A high PSA does not mean cancer is present and a normal PSA   does not rule out the presence of prostate cancer  The normal values for PSA are 0 to 4.    Borderline levels are 4 to 10 and when it is over 10 it is considered high.

    Prostatitis may artificially elevate PSA, a a rapid rise in PSA should usually be treated for several weeks with appropriate antibiotics and then repeated  

    The use of Proscar or Propecia  as well as many of the proprietary "prostate medicines" sold over the counter, which include saw palmetto will artificially lower PSA levels.  For patients on any of these drugs, the normal upper limit of PSA is reduced to 2-2.5. Patients using any of these medications should inform their doctors!!

    When the PSA levels are between 4 and 10 a second  fuzzy blood test, the Total vs. Free PSA ratio may be helpful.  While high ratios, over 25%, suggest benign disease, and low ratios, under 15%, suggest cancer, there are many false positive and negative results,  and the evaluation of the results are best left to a urologist.  This test is not  valid for PSA's less than 4 nor greater than 10.

    A third indicator is PSA velocity.  If the PSA is rising more than 0.7 per year it is considered suspicious and should be taken into the consideration for biopsy

    Sometimes when the PSA is borderline or elevated, or a nodule is present, and there are symptoms suggestive of infection or inflammation, the urologist, (this decision is best left to an expert), may decide to treat the condition with antibiotics for 2 to 4 weeks and repeat both the PSA and the examination.  If both examinations return to normal, cancer is usually not present, and a repeat examination in 3 to 6 months is indicated.                                                  Rev: 09/04

                                                          next [click here]

              [Back]  [Urologic Conditions]    [Evaluation]

         [Home]

Werner - Francis Urology Associates llc - Mid Atlantic Urology Associates llc

Greenbelt - Bowie - Laurel     Maryland

(301) 441-8900               Fax (301) 982 0453

7500 Hanover Parkway   Suite 206    Greenbelt, MD   20770

e-mail: wfurology@gmail.com

contact us

                                                                                   

Rev:03/08